1McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis,2005,25 ( Suppll ) :3 - 8.
2Xia GL,Liu CB, Cao HL, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population Int Hepatol Commun. 1996,5( 1 ) :62 -73.
4Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
2郑筱英.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
3Uzun L,Say R,Unal S. Hepatitis B surface antibody purification with hepatitis B surface antibody imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-L-tyrosine methyl ester)particles[J].J Chromatography B Analyt Technol Biomed Life Sci,2009,(03):181-188.
4Marcellin P,Chang TT,Lim SG. Adefovir dipivoxil for the treatment of hepatitis Be antigen-positive chronic hepatitis B[J].New Engl J Me,2003,(09):808.
6Shamliyan TA,Macdonald R,Shaukat A,et al.Antiviral therapy for adults withchronic hepatitis B:a systematic review for a nationalinst it utes of health consensus development conference[J].Ann Intern Med,2009,150(2):111-124.
